Search results for "AGEUSIA"

showing 6 items of 6 documents

COVID-19 and Alzheimer’s Disease

2021

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer’s Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to …

medicine.medical_specialtyNeurological injuryCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)neuroinflammation.DiseaseReviewneuroinflammationlcsh:RC321-57103 medical and health sciences0302 clinical medicineMedicineIntensive care medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroinflammation030304 developmental biologyNeurotropic virus0303 health sciencesneurodegenerative niseasebusiness.industrySARS-CoV-2General NeuroscienceHypogeusianervous systembiomarkersADAgeusiabiomarkermedicine.symptombusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Post-COVID-19 acute sarcopenia : physiopathology and management

2021

AbstractIn this review, we discuss the pathophysiologic and management aspects of acute sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious disease characterized by a severe inflammatory and highly catabolic status, influencing the deep changes in the body build, especially the amount, structure, and function of skeletal muscles which would amount to acutely developed sarcopenia. Acute sarcopenia may largely impact patients’ in-hospital prognosis as well as the vulnerability to the post-COVID-19 functional and physical deterioration. The individual outcome of the COVID-19 and the degree of muscle mass and functional loss may be influenced by multiple fact…

SarcopeniaAgingmedicine.medical_specialtymedicine.medical_treatmentAcute sarcopeniaAnosmiaReviewDiseaseCOVID-19 Sarcopenia Acute sarcopenia Rehabilitation Older adults Inflammaging03 medical and health sciencesPost-Acute COVID-19 Syndrome0302 clinical medicinemedicineHumans030212 general & internal medicineIntensive care medicineAgedRehabilitationSARS-CoV-2business.industryRehabilitationCOVID-19ImmunosenescenceAgeusiamedicine.diseaseInflammagingCognitive trainingInfectious disease (medical specialty)Older adultsSarcopeniaCommunicable Disease ControlGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - a possible pattern? Observational study and review …

2021

BACKGROUND: The cutaneous manifestations of coronavirus disease 2019 (COVID-19) have been covered insufficiently in the literature. METHODS: Thirty-nine patients admitted to the study hospital with confirmed COVID-19 who experienced various skin manifestations during hospitalization or in the convalescence period, were analysed retrospectively. RESULTS: Thirty-nine patients with COVID-19, admitted to the study hospital between 23 March and 12 September 2020, had intra-infectious rash or lesions of cutaneous vasculitis during convalescence. The most common cutaneous manifestations of COVID-19 were erythematous and erythematous papular rash. Twenty-seven of the 39 patients had anosmia (69.2%)…

0301 basic medicineMaleACE2 angiotensin‐converting enzyme 2ErythemaReceptor expressionTNF Tumor Necrosis Factor alphaInfectious and parasitic diseasesRC109-216B cells B lymphocyteslesions0302 clinical medicine030212 general & internal medicineskin and connective tissue diseasesCOVID coronavirus disease 2019media_commonEnterocolitisNK cells Natural killer cellsConvalescenceGeneral MedicineRashEnteritisInfectious DiseasesFemalemedicine.symptomCD Cluster of differentiationIHC immunohistochemistryMicrobiology (medical)medicine.medical_specialtyRT real-time reverse transcriptase–polymerase chain reactionmedia_common.quotation_subjectAnosmia030106 microbiologyAnosmiaSkin DiseasesArticle03 medical and health sciencesmedicineHumansbiopsySARS Severe acute respiratory syndrome coronavirus 2HE Hematoxylin and eosin stainRetrospective Studiescutaneous manifestationsbusiness.industrySARS-CoV-2SARS-CoV-2 infectionCOVID-19Ageusiamedicine.diseaseDermatologyPneumoniaIL 1 Interleukin 1IFN-γ Interferon γbusinessAgeusiaInternational Journal of Infectious Diseases
researchProduct

Differences in the Density of Fungiform Papillae and Composition of Saliva in Patients With Taste Disorders Compared to Healthy Controls

2017

International audience; This study investigated the relation of the fungiform taste papillae density and saliva composition with the taste perception of patients suffering from diagnosed taste disorders. For this purpose, 81 patients and 40 healthy subjects were included. Taste was measured by means of regional and whole mouth chemosensory tests, and electrogustometry. Olfaction was assessed using the Sniffin Sticks. Fungiform papillae were quantified using the "Denver Papillae Protocol for Objective Analysis of Fungiform Papillae". In addition, salivary parameters [flow rate, total proteins, catalase, total anti-oxidative capacity (TAC), carbonic anhydrase VI (caVI), and pH] were determine…

MaleSalivaTastefungiforme papillaePhysiology[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionsignal-detection measuresDentistryPhysiologyperceptiontasteBehavioral Neuroscience0302 clinical medicineMedicine030223 otorhinolaryngologyLingual papillaAged 80 and overElectrogustometryTaste PerceptionMiddle AgedTaste BudsSensory SystemsTaste disorderchorda tympani nerveFemalemedicine.symptomperformanceoleic-acidAdultgene polymorphismOlfactiontaste disordersbud density03 medical and health sciencesYoung Adultstomatognathic systemPhysiology (medical)HumansAgedsalivabusiness.industryBeck Depression Inventorytongue-regionAgeusiasensitivityCase-Control Studiesbusinessintensity[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgery
researchProduct

An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection

2020

Introduction: Since the beginning of the Covid-19 epidemic produced by SARS2-Cov virus, olfactory alterations have been observed at a greater frequency than in other coronavirus epidemics. While olfactory alterations may be observed in patients with rhinovirus, influenza virus, or parainfluenza virus infection, they are typically explained by nasal obstruction with mucus or direct epithelial damage; in the case of SARS-CoV-2, olfactory alterations may present without nasal congestion with mucus. We performed a study of patients presenting olfactory/gustatory alterations in the context of SARS-CoV-2 infection in order to contribute to the understanding of this phenomenon. Material and Method…

AdultMalevirusesCentral nervous systemAnosmiacoronavirusPhysiologyNasal congestion03 medical and health sciencesOlfaction DisordersTaste Disorders0302 clinical medicineonline questionnaireHyposmiaSurveys and QuestionnairesmedicineHumans030212 general & internal medicineOriginal Researcholfactory alterationsneurologicalbusiness.industrySARS-CoV-2030503 health policy & servicesHypogeusialcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270Ageusiarespiratory systemDysosmiaDysgeusiamedicine.anatomical_structureCross-Sectional StudiesFemalePublic Healthmedicine.symptom0305 other medical sciencebusinessCovid-19anosmiaFrontiers in Public Health
researchProduct

Meshing individual differences in taste sensitivity with genotype: cSNPs in candidate taste receptors for glutamate are necessary but not sufficient …

2007

International audience

[SDV] Life Sciences [q-bio]TASTE SENSITIVITYGLUTAMATE[SDV]Life Sciences [q-bio]TASTE RECEPTORS[INFO]Computer Science [cs][INFO] Computer Science [cs]ComputingMilieux_MISCELLANEOUSGENOTYPEAGEUSIA
researchProduct